A Cost-effectiveness Study of the Quadrivalent HPV6/11/16/18 Vaccination in a Two-dose Scheme in Girls of 9-11 Years Old Compared to Bivalent HPV 16/18 Vaccination in Ecuador and Challenges for Public Health and Screening
Journal Title: International STD Research & Reviews - Year 2017, Vol 6, Issue 1
Abstract
Aims: Assess the incremental cost-effectiveness of the quadrivalent HPV6/11/16/18 vaccination as administered in a two-dose scheme to girls between 9 and 11 years old, as compared to the bivalent HPV 16/18 vaccination administered in Ecuador, and to estimate the cost-saving of preventing GW while preventing cervical cancer with both vaccines. Study Design: We used a previously developed transmission dynamic mathematical model to evaluate the impact of routine vaccination of 9-11 year-old females. The model assumed coverage of 90% for two doses of HPV6/11/16/18 vaccine at international price rates versus HPV16/18 vaccine and costs for genital warts treatment. Other simulation parameters include: country socio- demographic variables, sexual behavior and screening parameters among Ecuadorian girls. Results: Over a 100-year period, HPV6/11/16/18 vaccination would result in reductions of HPV 6/11-related disease incidence at the population level as follows: genital warts in females (81.3%), genital warts in males (78.9%) and HPV6/11-related CIN1 (79.7%). These results would translate into a reduction of HPV 6/11-related disease cost of between 52% to 56% for genital warts among females, genital warts among males, and HPV6/11-related CIN1. Under the model assumptions, the estimated net cost of vaccination with the HPV6/11/16/18 vaccine from a public health perspective would be close to -USD$256 million. Adjusted to the net present value, this cost-saving represents USD$180,735,849.09 with a present value interest factor of 0.9512. Conclusions: In Ecuador, routine vaccination of 9-11 year old females with a quadrivalent HPV6/11/16/18 vaccine is cost-saving compared to a bivalent HPV 16/18 vaccine, which suggests a significant public health and economic impact.
Authors and Affiliations
Maria Isabel Roldós, Isabel Espinosa, Amit Kulkarni, Matthew Pillsbury, Andrew Pavelyev, Homero A. Monsanto, Diego Guarín, Miguel Cashat-Cruz
Keywords
Related Articles
- EP ID EP305407
- DOI 10.9734/ISRR/2017/35382
- Views 113
- Downloads 0
Sexual Transmitted Infection (STI) Risk Associated with Beliefs about Virginal Sex and Perceived Social Norms among Inmates in KwaZulu Natal
This study examines the association between self-reported beliefs of primarily Zulu speaking inmates regarding virginal sex and its perceived utility for the prevention of HIV/AIDS and STIs and its impact of perceived so...
Youths' Reproductive Health and Risk Perception to Sexually Transmitted Infections in Communities in Bayelsa State, Nigeria: A Qualitative Study
Aims: Young people especially in sub-Saharan Africa are at great risk of contracting HIV. Studies have shown that young people aged 15–24 account for an estimated 45% of new HIV infections worldwide while less than half...
Lime Juice Induces Ovarian Follicle Degeneration and Reduces Serum Gonadotrophin Level in Rats Model
Background: Lime juice possesses antimicrobial and anti-proliferative property and caused reduced sperm motility in animals. This study aimed at investigating the anti-proliferative effect of lime juice on the ovarian co...
Modeling the Global Public Health Determinants of HIV/AIDS-Related Deaths
The alarming global incidence of HIV/AIDS epidemic prompted this research undertaking to explore several health indicators that lead to and mediate reported HIV/AIDS mortality. A number of studies attempted to explore an...
Correlates of Vulvovaginal Candidiasis among Attendees of a Special Treatment Clinic in Nigeria
Background: Vulvovaginal candidiasis (VVC) is very common with significant morbidity and health expenditure. Many cases are associated with concurrent infections with other sexually transmitted infections and several fac...